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Summary
MAP kinases bind activating kinases, phosphatases,
and substrates through docking interactions. Here,
we report a 1.9 A˚ crystallographic analysis of inac-
tive ERK2 bound to a ‘‘D motif’’ docking peptide
(pepHePTP) derived from hematopoietic tyrosine
phosphatase, a negative regulator of ERK2. In this
complex, the complete D motif interaction defined by
mutagenic analysis is observed, including extensive
electrostatic interactions with the ‘‘CD’’ site of the
kinase. Large conformational changes occur in the
activation loop where the dual phosphorylation sites,
which are buried in the inactive form of ERK2, become
exposed to solvent in the complex. Similar conforma-
tional changes occur in a complex between ERK2 and
a MEK2 (MAP/ERK kinase-2)-derived D motif peptide
(pepMEK2). Dmotif peptides are known to bind homol-
ogous loci in the MAP kinases p38a and JNK1, also
inducing conformational changes in these enzymes.
However, the binding interactions and conformational
changes are unique to each, thus contributing to spec-
ificity among MAP kinases.
Introduction
MAP kinases (MAPKs) function in eukaryotes to respond
adaptively to extracellular stimuli. Over a dozen homol-
ogous mammalian MAPKs have been identified, and
each interacts with several different kinds of protein
molecules. First, MAPKs are activated by MAP/ERK
kinase kinases (MAP2Ks/MEKs/MKKs) via phosphoryla-
tion of a Thr-X-Tyr motif in the MAPK activation loop. In
turn, activated MAPKs phosphorylate diverse nuclear
transcription factors and cytosolic enzymes. Further, in-
activation of MAPKs is achieved by dephosphorylation
of either or both pThr and pTyr by different classes of
protein phosphatases, tyrosine phosphatases (PTPs),
serine/threonine phosphatases, or dual specificity
phosphatases (MAP kinase phosphatases, or MKPs; re-
viewed in Lewis et al., 1998 and Pearson et al., 2001).
Given that there are many MAPKs, functioning in dif-
ferent MAP kinase pathways by interacting with
*Correspondence: elizabeth.goldsmith@utsouthwestern.edudifferent proteins, mechanisms must be in place to
assure specificity.
A body of data is accumulating that docking motifs in
MAP kinase substrates and processing enzymes (acti-
vating kinases and downregulating phosphatases) me-
diate MAPK interactions. Docking motifs are known to
be remote from the phosphorylation sites in substrates
or from the active sites of the processing enzymes (re-
viewed in Biondi and Nebreda [2003], Sharrocks et al.
[2000], and Tanoue and Nishida [2002]). The docking
motif binding sites in MAPKs are also known to be re-
mote from the MAPK active sites (Biondi and Nebreda,
2003; Sharrocks et al., 2000; Tanoue and Nishida,
2002). The best studied docking motifs are the ‘‘D mo-
tifs,’’ also known as d-domains, DEJL motifs, D domains,
or kinase interaction motifs (Kallunki et al., 1996; Lee
et al., 2004; Pulido et al., 1998; Sharrocks et al., 2000).
Extensive mutational analysis has revealed that each
of the mammalian MAP kinases, p38s, JNKs and ERKs,
bind similar yet distinct substrate and processing
enzyme D motifs. The canonical D motifs possess both
basic and hydrophobic residues in the arrangement
(Arg/Lys)1–2-(X)2–6-ØA-X-ØB (where ØA and ØB are hy-
drophobic residues [Leu, Ile, or Val]). Related motifs
present in substrates, such as MAPKAP kinase-1, have
additional hydrophobic residues N-terminal to the basic
motif (Gavin and Nebreda, 1999; Smith et al., 1999). D
motifs bind to similar loci in each MAPK, which we will
refer to here as the D motif binding site. Mutagenic stud-
ies have shown that the D motif binding site is com-
prised in part of an acidic patch (Asp316 and Asp319
in rat ERK2, named the CD site) (Tanoue et al., 2000;
Zhang et al., 2003) as well as nearby residues (Tanoue
et al., 2000; Zhang et al., 2003). Crystallographic studies
of p38a (Chang et al., 2002) and JNK1 (Heo et al., 2004)
bound to D motif peptides, as well as mutagenic analy-
sis (Gum and Young, 1999), revealed that the D domain
binding site further spans a hydrophobic groove be-
tween helices aD and aE and the b7-b8 reverse turn.
The two crystallographic analyses also revealed long-
range conformational changes in the presence of D
motif peptides in p38a and JNK1, including induction
of disorder in the activation loop of the kinase. Induction
of disorder was confirmed in hydrogen exchange mass
spectrometry studies (Lee et al., 2004). These observa-
tions suggest that D motif docking interactions cause
allosteric effects.
To further study the specificity of MAP kinase D motif
docking interactions and allosteric effects, we have de-
termined the crystal structure of inactive ERK2 in com-
plex with a D motif peptide derived from hematopoietic
protein tyrosine phosphatase (16RLQERRGSNVALML
DV31, pepHePTP). In addition to downregulating ERK2
by dephosphorylating pTyr185 in active ERK2, HePTP
associates with inactive ERK2, retaining the enzyme in
the cytoplasm (Pulido et al., 1998; Saxena et al., 1999;
Zuniga et al., 1999). PepHePTP was shown to bind to
ERK2 with a KD of 5 mM (Zhou et al., 2001), and ERK2-
pepHePTP complexes formed crystals. Disulfide tether-
ing (Erlanson et al., 2004) was used to further reduce the
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1012Figure 1. The Crystal Structure of Inactive
ERK2 in Complex with pepHePTP
(A) Electron density (j2Fo 2 Fcj, contoured at
0.9 s) of pepHePTP (16RLQERRGSNVAL
MLDV31) in the wild-type ERK2-pepHePTP
complex, determined at 2.9 A˚ resolution.
Val310 is not visible in the density. ‘‘N’’ and
‘‘C’’ denote the termini of the bound peptide.
(B) Electron density (j2Fo 2 Fcj, contoured at
1.0 s) for the cysteine mutant peptide,
pepHePTP/V310C (16RLQERRGSNVALM
LDC31), bound to ERK2/T116C (at 1.9 A˚ reso-
lution) (ERK2-pepHePTPm).
(C) Electron density (j2Fo 2 Fcj, contoured at
1.0 s) of the activation loop in ERK2-
pepHePTPm, between Asp173 and Thr188.
The dual phosphorylation site residues
(Thr183 and Tyr185) are labeled.
(D) Ribbon diagram of the ERK2-pepHePTPm
complex. PepHePTPm is colored yellow. The
dual phosphorylation site residues of ERK2
(Thr183 and Tyr185) are shown as sticks.
(E) D motif peptide and binding site;
pepHePTPm is shown in green ribbons and
sticks, ERK2 is shown as a white transparent
surface and magenta ribbons. E79 and D319
of ERK2 are shown as sticks. The mutation
in the peptide, V310C, is also shown. The hy-
drophobic docking groove is labeled HDG.
Figure drawn in PyMOL (DeLano, 2002).mobility of the peptide in the ERK2-peptide complex,
producing crystals that diffract to 1.9 A˚. In this complex,
an intricate electrostatic network connects HePTP to
ERK2 in the CD site, accounting for previous mutagenic
analysis. Long-range conformational changes are ob-
served in which the activation loop adopts a conforma-
tion distinct from either inactive or active ERK2. A com-
plex between ERK2 and a peptide (pepMEK2) derived
from the activating kinase MEK2 produced crystals in
the same space group. Although the electron density
for pepMEK2 was weak, conformational changes similar
to those in ERK2-pepHePTP were observed. We discuss
the possibility that these allosteric conformational
changes contribute to pathway specificity by making
the phosphorylation sites available to pathway-specific
kinases and phosphatases.
Results and Discussion
Structure Determination
The structure of unphosphorylated (inactive) ERK2 in
complex with the 16-mer D motif peptide (pepHePTP)
with the sequence 16RLQERRGSNVALMLDV31 was
solved by molecular replacement, as described in
Experimental Procedures, by using inactive ERK2 as
the search model (Protein Data Bank code 1ERK). The
difference electron density map, calculated by using
reflections to 2.9 A˚ resolution, revealed all of the resi-
dues in the peptide except Val310 (0 denotes peptide)
(Figure 1A). Model building based on this structure sug-
gested that a mutant peptide, pepHePTP/V310C, might
form a disulfide bond with a mutant ERK2, ERK2/
T116C, in analogy with the disulfide bridge that occursin the p38a-pepMKK3b complex (Chang et al., 2002).
The ERK2 mutant T116C and a peptide with the se-
quence 16RLQERRGSNVALMLDC31 were synthesized.
The complex, ERK2/T116C-pepHePTP/V310C (referred
to below as ERK2-pepHePTPm), crystallized under the
same condition as does the wild-type but diffracted
much better, to 1.9 A˚. The structure was solved and
refined as described in Experimental Procedures (to
a free R factor and R factor of 26% and 22%, Table 1).
In this complex, the bound peptide is clearly visible (Fig-
ure 1B), as is the activation loop (Figure 1C). The struc-
ture of ERK2-pepHePTPm is described below. Crystals
of the complex ERK2-pepMEK2 formed under similar
conditions, gave 2.0 A˚ data, and were partially refined
(see Experimental Procedures). The protein model for
ERK2-pepMEK2 superimposes with a root mean square
deviation (rmsd) of 0.4 A˚ with ERK2-pepHePTPm and
thus is quite similar. However, the electron density for
the peptide was poorly defined (data not shown). All of
the structures, ERK2-pepHePTP, ERK2-pepHePTPm,
and ERK2-pepMEK2, superimpose with unphosphory-
lated ERK2 with an rmsd ofw2.4 A˚. The origin of these
large rmsds is discussed below.
The final refined model of ERK2-pepHePTPm includes
all of ERK2, except nine residues in the N terminus (and
the His6 tag), and four residues in the C terminus (355–
358) (Figure 1D). Also, six residues near the N terminus
(residues 10–15) and four residues in the Gly-rich loop
(29–32) are partially disordered. In addition, part of the
activation loop (174–177) and part of L16 (329–335)
(L16 comprises residues 313–354 and is the linker that
crosses between the two domains of ERK2 [Zhang
et al., 1994]) have higher thermal parameters in the com-
plex (discussed below).
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1013Table 1. Crystal Data and Refinement Statistics
ERK2-pepHePTPm ERK2-pepHePTP (Wild-Type)a ERK2-pepMEK2a
Space group P212121 P212121 P212121
Unit cell dimensions (A˚) a = 46.0, b = 66.3, c = 116.1 a = 45.9, b = 66.0, c = 116.4 a = 45.5, b = 65.3, c = 117.3
Wavelength (A˚) 0.97112 0.97993 1.5418
Resolution (A˚) 1.9 2.9 2.0
No. of total observation 1,697,416 450,547 310,945
No. of unique reflections 29,041 8,779 24,424
Completeness (%) (last shell) 94.7 (70.8) 97.6 (93.6) 93.7 (63.2)
Intensities I/s (last shell) 19.7 (2.2) 27.8 (3.9) 54.5 (5.0)
bRmerge (last shell) 0.062 (0.289) 0.072 (0.41) 0.033 (0.31)
cRwork/
dRfree 0.22/0.26 0.24/0.30 0.27/0.31
Non-H protein atoms 2,952 2,928 2,825
No. of reflections in refinement 25,566 7,925 22,312
Rmsd in bond length (A˚) 0.010 0.012 0.009
Rmsd in bond angle (º) 1.47 1.74 1.51
Average B values (A˚2) 56.6 33.1 51.1
Ramachandran plot statistics (%)
Residues in most favored region 84.9 80.9 84.2
Residues in additionally allowed region 13.8 15.7 12.7
Residues in generously allowed region 1.2 2.5 1.9
Residues in nonallowed region 0 0.9 1.2
a Partially refined structures.
b Rmerge=
P
hkl[(
P
jjIj 2 <I>j)/
P
jjIjj].
c Rwork =
P
hkl jFo 2 Fcj/
P
hkl jFoj, where Fo and Fc are the observed and calculated structure factors, respectively.
d Rfree is the R factor calculated for a randomly selected 5% of the reflections that were omitted from the refinement.Structure of pepHePTP Bound to ERK2
In the complex ERK2-pepHePTPm, pepHePTP adopts
a helical conformation at its N terminus between
16RLQERR21, and the remainder of the peptide is ex-
tended (Figures 1D and 1E). Hydrogen bonding within
the helix as well as a hydrogen bond between Gln180N32
(in the helix) and Val250O (in the extended region) stabi-
lizes interactions internal to the peptide.
The D motif binding site is comprised of the CD site
and hydrophobic docking groove observed in p38a
and JNK1 (HDG in Figure 1E), and a surface depression
between these sites formed where L16 binds across he-
lix aE. The pocket is further delimited by b8 and the
V-shaped linker connecting aC and b4 (Figure 1E). The
helix binds to the surface depression, the basic region
of pepHePTP (20RR21) binds the CD site, and the ØA-
X-ØB (
27LML29) binds in the hydrophobic docking
groove (Figures 1D and 1E). In a recently reported struc-
ture of the yeast MAPK Fus3 bound by D motif peptides,
a similar locus of interaction was observed (Remenyi
et al., 2005).
Interactions in the CD Site
The CD site of ERK2 is an acidic patch (Asp316 and
Asp319) implicated in docking interactions (Tanoue
et al., 2000). In the complex, Asp319 makes direct
contacts with the peptide; both Arg200 and Arg210 bind
intimately to Asp319 (Figure 2A). Asp319O32 makes
two hydrogen bonds with the guanidinium group of
Arg210 (through the Nh1 and Nh2 atoms). Arg200 also
makes a bidentate interaction with Asp319O32, through
the N3 and Nh2 atoms. Arg200 (Nh1 and Nh2) further
makes a second bidentate interaction with Glu79 (in
the V-shaped linker), thus forming an elaborate network
of charged and hydrogen bonding interactions involving
all of these residues as well as Tyr129 and Arg133 in aE
(Figure 2A). Tyr129OH (in helix aE) makes two hydrogenbonds with Arg210, through Nh2 and N3. Arg133 extends
the network of electrostatic interactions by binding to
Glu79. Nearby, Tyr126 makes a hydrogen bond with
the main chain amide of Gln180 (data not shown), and
Tyr314, which precedes the CD site in L16, makes con-
tacts with Ser230Og (Figure 2A). Further, the helix
16RLQERR21 is stabilized by hydrophobic interactions
between Leu170 and Tyr126 and Tyr129 (Figure 2A).
Most of the residues in ERK2 that form direct contacts
with pepHePTP, including Asp 319, Glu79, and Tyr126,
were implicated in mutagenesis studies (Huang et al.,
2004; Tanoue et al., 2000; Zhang et al., 2003). Other res-
idues thought to be involved in binding, including Asp
316 and Tyr315 (Xu et al., 2001; Zhou et al., 2001),
instead appear to stabilize the CD site. The ERK2/
Tyr314-pepHePTP/Ser230 interaction is especially
telling because Ser230 of HePTP is phosphorylated by
protein kinase A during T cell activation, inducing disso-
ciation of the ERK2-HePTP complex (Saxena et al.,
1999).
Interactions in the Hydrophobic Docking Groove
The ØA-X-ØB sequences within D motifs bind to p38a
(Chang et al., 2002) and JNK1 (Heo et al., 2004) in a
hydrophobic groove flanked by helices aD and aE and
the b7-b8 reverse turn. Sequence alignments suggest
that the ØA-X-ØB motif of HePTP is
27LML29. Leu290
(ØB) of pepHePTP makes van der Waals contacts with
Leu113 from aD, Phe127 from aE, Leu155 from b7,
Cys159 in the b7-b8 hairpin, and to a lesser extent,
Thr108 in the crossover connection (Figure 2B). Leu270
(ØA) of pepHePTP binds to a hydrophobic patch on the
surface of helix aE, formed by His123 and Tyr126, both
in aE, and Cys159 in the b7-b8 hairpin. The interactions
made by ØB of pepHePTP are similar to those made
by ØA of pepMEF2A (peptide derived from MEF2A)
bound to p38a (discussed below). Val310 (ØB + 2) in
Structure
1014Figure 2. Binding Interactions in the ERK2-
pepHePTPm Complex
(A) Stereoview of the local interactions be-
tween the basic region of pepHePTP (yellow)
and the CD site of ERK2 (pink). Dotted lines
denote hydrogen bonds (2.6–3.4 A˚).
(B) Stereoview of the docking interactions of
the ØA-X-ØB motif of pepHePTP/V31
0C
(yellow) in the hydrophobic docking groove
of ERK2/T116C (pink). The ØA (L27
0) and ØB
(L290) residues of pepHePTP/V310C are
labeled.ERK2-pepHePTP is not visible in the electron density
(Figure 1A). In ERK2-pepHePTPm, Cys310 faces away,
forming the expected disulfide bridge with Cys116 of
ERK2/T116C (Figure 1E).
Three hydrogen bonds connect the backbone of the
ØA-X-ØB motif to ERK2. Two bonds link Gln117 to the
main chain carbonyl of Met280 (the X in ØA-X-ØB) and
the main chain amide of Asp300 (ØB + 1), and one hydro-
gen bond links His123 to the main chain carbonyl ofMet280 (Figure 2B). These interactions are similar to
those observed in p38a (Chang et al., 2002).
Peptide-Induced Conformational Changes
Conformational changes accompany formation of the
complex between ERK2 and pepHePTP. The main loci
of these changes are the CD site, L16, the activation
loop, the Gly-rich loop, the N terminus, and the MAP ki-
nase insert (Figure 3A). The peptide-induced structure isFigure 3. Peptide-Induced Conformational
Changes in ERK2
(A) Global superposition of the ERK2-
pepHePTPm complex (pink) with inactive
ERK2 (blue). The regions of conformational
changes in ERK2-pepHePTPm, including
the CD site, L16, the activation loop, the
Gly-rich loop, the N terminus, and the loop
in MAP kinase insert, are highlighted in red.
(B) Closed-up view of the conformational
changes in the CD site. ERK2 in ERK2-
pepHePTPm is shown in light pink, and
inactive ERK2 in light blue. The bound
pepHePTPm in ERK2-pepHePTPm is colored
yellow.
(C) Stereoview showing the conformational
changes in L16 and the activation loop, where
a new interaction between the two forms in
the ERK2-pepHePTPm complex. ERK2-
pepHePTPm is shown in light pink, and inac-
tive ERK2 in light blue.
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unphosphorylated ERK2 (2.4 A˚).
The CD Site
Several residues local to pepHePTP move in forming the
complex. These are Ser318, Asp319, Lys136 (in helix
aE), Glu303 (in helix aI), and Glu79 (Figure 3B). Lys136,
Glu303, and Glu320 make an electrostatic network
among themselves and also involve Tyr129 and
Tyr315, thus establishing an extensive and unusual elec-
trostatic network that includes Arg200 and Arg210 of
pepHePTP.
In making the complex, the side chain of Glu79 rotates
to form a salt bridge to Arg200. Four residues away from
Glu79, Arg75 in helix aC releases a salt bridge with
Asp324 in L16 in forming the complex with pepHePTP
(Figure 3C). This change appears to occur in conjunction
with the movement of Glu79 in the V-linker and thus
helps to explain the massive conformational changes
in L16.
Loop L16
The CD site is located at the N terminus of L16. L16 is the
locus of major changes between inactive and active
ERK2 (Canagarajah et al., 1997; Zhang et al., 1994) and
is the site of dimerization in active ERK2. In the ERK2-
pepHePTPm complex, L16 adopts a conformation dis-
tinct from both active and inactive ERK2. The largest
changes involve the backbone of L16 between Asp324
to Asp335 (Figure 3C). Asp324 loses a contact with
Arg75 in helix aC, and Phe329, which is buried in inactive
ERK2, moves to the surface in the complex. The
peptide-induced conformation of L16 involves new
activation loop contacts, thus stabilizing the observed
conformation of the activation loop (Figure 3C). Specific
interaction changes include movement of Asp173 in the
activation loop, which loses a contact with His176N ob-
served in inactive ERK2 and makes a new contact in the
complex, with Asp330N in L16. Thus in ERK2, it appears
that the conformational linkage between the CD site and
the activation loop is mainly through L16.
Activation Loop
In ERK2-pepHePTPm, the activation loop adopts a con-
formation that is different from either unphosphorylated
(inactive) or phosphorylated (active) ERK2 (Figure 3A).
The loop is visible in the electron density map (Fig-
ure 1C), except three partially disordered residues
(Pro174, Asp175, and Glu184). The structure of the
loop deviates from that of unphosphorylated ERK2
between Ala172 and Arg189. The phosphorylation site
residues, Thr183 and Tyr185, face outward in the com-
plex, making loose contacts with a neighboring mole-
cule (contacts not shown). Tyr185 undergoes the largest
change, moving over 15 A˚. Phe181 and Leu182, which
contact the MAP kinase insert in unphosphorylated
ERK2, also move significantly (making contacts with
Arg146 in the catalytic loop; data not shown). The activa-
tion loop of ERK2-pepHePTP differs from both active
ERK2 (rmsd of 3.5 A˚ from Asp173 to Thr188) and inactive
ERK2 (3.9 A˚).
Other Conformational Changes
In ERK2-pepHePTPm, conformational changes also oc-
cur in the N terminus, in the Gly-rich loop and in the MAP
kinase insert (Figure 3A). The N terminus is a locus of
conformational differences between inactive and active
ERK2 (Canagarajah et al., 1997; Zhang et al., 1994). InERK2-pepHePTPm, the N terminus refolds and looks
more like active ERK2 (data not shown). The function
of this conformational change is unknown, although in
a recent study of the Saccharomyces MAP kinase
Fus3, in complex with the scaffold Ste5 (Bhattacharyya
et al., 2006), this site was identified as a second docking
locus for Ste5.
Conservation and Variability of D Motifs
that Target ERKs
The ERK2-pepHePTP complex provides a structural
explanation for conservation among D motifs and an ap-
proximate model for other ERK2/D motif interactions.
Arg200 and Arg210 in pepHePTP are conserved in most
D motifs, and thus other D motifs may form similar inter-
actions (Figure 4A). Further, a hydrophobic residue near
the N terminus and in the helix (labeled ØH in Figure 4A)
is conserved in a subset of D motifs targeting ERK1/2.
Most PTPs, some substrates such as RSK1 and Mnk1,
and some MEKs possess ØH. The interactions made
by Leu170 (ØH in pepHePTP) appear to stabilize the helix
of pepHePTP, as discussed above. Thus, a helix might
be present in other D motifs that have ØH. Similarly,
ØA-X-ØB is conserved only in a subset of D motifs and
is missing from MAPKAPs. Thus, the D motif inter-
actions can be described as ‘‘hydrophobic-basic-
hydrophobic’’ (in phosphatases), ‘‘hydrophobic-basic’’
(in MAPKAPs), or ‘‘basic-hydrophobic’’ (in MEK1 and
the transcription factor substrates) (Figure 4A). Similar
Figure 4. Sequence Alignment and Comparison of D Motifs
(A) Comparison of D motifs of HePTP with other molecules targeting
ERKs. HePTP, STEP (striatum-enriched PTP), and PTP-SL (STEP-
like PTP) are protein tyrosine phosphatases (PTPs); MKP3, Pyst2,
MKP4, and hVH3 are dual specificity phosphatases (MKPs); RSK1
and Mnk1 are MAPKAPs; ELK1, LIN1, and SAP1 are transcription
factors, and MEK1 and MEK2 are activator MAP2Ks. The N-terminal
hydrophobic residue (ØH), the positively charged residues (basic),
and the ØA-X-ØB motif (ØA-X-ØB) in the D motifs are indicated.
(B) Structure-based alignment of the D motif peptides studied crys-
tallographically in complex with ERK2, p38a, and JNK1. The ØA and
ØB residues are colored orange. The alignment of the ØA-X-ØB motif
of pepHePTP is shifted with respect to the docking motifs studied in
p38a and JNK1 to reflect the difference in structures (see Figure 5).
Sequence data taken from (Sharrocks et al., 2000).
Structure
1016Figure 5. Comparison of D Motif Interactions
in the Hydrophobic Docking Groove among
ERK2, p38a, and JNK1
(A) Local superposition between ERK2 (light
pink) in complex with pepHePTPm (orange)
and p38a (light blue) in complex with
pepMEF2A (dark blue), in the hydrophobic
docking groove. The disulfide bond observed
between ERK2/T116C and pepHePTP/V310C
is also shown.
(B) Superposition between ERK2 (light pink)
in complex with pepHePTPm (orange) and
JNK1 (light green) in complex with pepJIP1
(dark green) in the hydrophobic docking
groove. Note that Leu290 of HePTP binds
similarly to L2750 of pepMEF2A in p38a, and
Leu1600 of Jip1 in JNK1 (pepJip1).heterogeneity exists in D motifs that target other MAP ki-
nases (Tanoue et al., 2000). Also, in yeast MAP kinase
docking motifs, there is heterogeneity in the spacing be-
tween the basic region and the ØA-X-ØB (Remenyi et al.,
2005), giving rise to distinct conformations in the yeast
docking peptides.
Comparison of D Motif Interactions
among MAP Kinases
It is now apparent that each of the mammalian MAP ki-
nases, ERK2, p38a, and JNK1, bind D motif peptides
at the same locus but make different interactions with
their respective docking partners. First, there is a major
difference in the interaction mode of the ØA-X-ØB motifs,
where a structure-based sequence alignment reveals
a difference in registration between ERK2 and p38a
and JNK1 (Figure 4B): Leu290, ØB of pepHePTP, oc-
cupies the position held by ØA in p38a (Chang et al.,
2002) and JNK1 (Heo et al., 2004) (Figures 5A and 5B).
The ØA residue (Leu27
0) binds in the pocket filled by
the ØA-2 residue (Leu273
0) in the p38a-pepMEF2A com-
plex. In the JNK1-pepJIP1 complex, a third arrangement
is observed, in which Pro1570 (ØA-3) of pepJIP1 roughly
occupies this position (Figure 5B). A possible explana-
tion for this change in registration is that the ØB binding
pocket present in p38a and JNK1 is blocked off by
Thr108 in ERK2 (Figures 2B and 5). In p38a and JNK1,
the homologous residue is alanine, which is smaller,
thus creating a pocket. Second, intricate electrostatic
interactions are observed in the CD site of ERK2 but
not in p38a or JNK1. In both p38a-pepMEF2A and
p38a-pepMKK3b complexes, no interactions to the CD
site were observed (Chang et al., 2002). In JNK1, the in-
teraction made to the CD site (Glu329) is only by a single
residue, Arg1560 (ØA-4) of pepJIP1 (data not shown) that
is not conserved in other JNK1-interacting molecules
such as c-Jun and MKK7 (Heo et al., 2004). In the re-
cently reported structures of the yeast MAPK Fus3 in
complex with MEK-derived and substrate-derived pep-
tides (Remenyi et al., 2005), the peptides make contacts
at both ØB and ØA-2 positions in the hydrophobic dock-
ing groove and form similar interactions in the CD site as
observed here.
Although p38a and JNK have greater sequence simi-
larity (Kultz, 1998), differences in D motif interactions
do not fall strictly on ERK2 versus p38a and JNK1 lines.
For example, both ERK2 and p38a bind the backbone ofthe ØA-X-ØB sequence with corresponding glutamines
(ERK2/Gln117 and p38a/Gln120) and histidines (ERK2/
His123 and p38a/His126). These amino acids are re-
placed by Met121 and Arg127 in JNK1 (Figure 5B),
and, therefore, the hydrogen bonding interactions are
missing or different. On the other hand, Tyr126 of
ERK2, which makes contacts with Leu170 and Gln180
of pepHePTP, is conserved in JNKs but not in p38s (re-
placed by Phe). Tyr129 of ERK2 is highly conserved
throughout the MAP kinase family and thus may form
similar interactions in other MAP kinases. Finally,
Glu79 of ERK2 is conserved in p38s and replaced with
a Lys in JNKs. This change in JNKs, together with the
Glu to Asp substitution in the CD site (Glu329 in JNK1),
suggests that electrostatic interactions in the CD site
of JNKs will be different.
Comparison of Peptide-Induced Conformational
Changes among MAP kinases
Local and long-range peptide-induced conformational
changes differ among MAP kinases (Figure 6). First,
changes local to the D motif binding site are quite differ-
ent: in ERK2, conformational changes occur in the CD
site, but in p38a, changes occur in the hydrophobic
docking groove. Second, in ERK2, the activation loop
adopts a new conformation while in p38a (Chang et al.,
2002) and JNK1 (Heo et al., 2004), docking interactions
induce disorder in the activation loop. Third, ERK2 un-
dergoes large conformational changes in L16 where
a new direct interaction with the activation loop forms.
These changes appear to be triggered by the conforma-
tional changes in the CD site. In p38a, no conformational
changes occur along L16. Instead, helix aD changes
shape near the ØA-X-ØB docking groove and becomes
detached from the underlying structure (helix aF and
the linker between helices aF and aG) (Figure 6, middle)
(Chang et al., 2002). No similar conformational changes
were noted in the study of Fus3 bound by docking pep-
tides (Remenyi et al., 2005), although changes did occur
in Fus3 when bound by peptides derived from the scaf-
fold Ste5 (Bhattacharyya et al., 2006).
A Third Conformation for the Activation Loop
of ERK2
The structure of the activation loop of ERK2-
pepHePTP is unlike either uphosphorylated or phos-
phorylated ERK2 (Figure 7A). The structures of the
Docking Motif Interactions in the MAP Kinase ERK2
1017Figure 6. Comparison of Docking Peptide-In-
duced Conformational Changes in ERK2,
p38a, and JNK1
Superpositions are based on inactive ERK2
(blue) (PDB code 1ERK) and ERK2-
pepHePTPm (salmon) (this study), inactive
p38a (blue) (1P38) and p38a-pepMEF2A
(salmon) (1LEW), and inactive JNK3 (blue)
(1JNK) and JNK1-pepJIP1 (salmon) (1UKH).
Bound peptides are shown in yellow. In
ERK2 and p38a, global superpositions are
made, whereas in JNK3/JNK1-pepJIP1,
superposition is made against the C-terminal
domain of the two kinases. ‘‘A-loop’’ denotes
activation loop. Note the disorder in the acti-
vation loops of p38a-pepMEF2A and JNK1-
pepJIP1.ERK2-pepMEK2 and ERK2-pepHePTPm are very simi-
lar, superimposing with an rmsd of 0.4 A˚, showing that
both peptides induce this conformation. What, then, is
the function of this third conformation? In unphosphory-
lated ERK2, the two phosphorylation site residues
(Thr183 and Tyr185) are buried and thus inaccessible
to solvent (Zhang et al., 1994). This is likely to be a mech-
anism to avoid adventitious activation of ERK2 by other
kinases. Since in ERK2-pepHePTPm (and ERK2-
pepMEK2) the activation loop adopts a conformationin which the two phosphorylation site residues are ex-
posed to solution, this D motif bound conformation
may make the phosphorylation sites available for pro-
cessing by pathway-specific kinases (Figure 7B). It is
yet to be determined whether D motif peptides induce
conformational changes in active kinases. However, D
motif interactions in both inactive p38a (Chang et al.,
2002) and inactive JNK1 (Heo et al., 2004) induce dis-
order in the activation loop, suggestive of a similar
mechanism.Figure 7. Conformations of the MAP Kinase
ERK2
(A) The three conformations of the activation
loop of ERK2, the inactive form (left) (Zhang
et al., 1994), the putative processing confor-
mation (middle) (this study), and the active
form (right) (Canagarajah et al., 1997). The
phosphorylation site residues (Thr183 and
Tyr185) or the phosphoamino acids
(pThr183 and pTyr185) are shown in stick
representation.
(B) Cartoon of the conformational change
induced in ERK2 by pepHePTP that exposes
the activation loop to solvent (drawn in Adobe
Illustrator).
Structure
1018Docking and Allostery Contribute
to Pathway Specificity
It appears that docking and allostery may be important
mechanisms by which MAP kinases improve pathway
specificity. First, the allosteric mechanism may allow
only specific kinases and phosphatases to access the
phosphorylation sites, as discussed above. Second,
the allostery may serve to reduce the affinity of the D
motif for its targeted MAP kinase while maintaining
selectivity. Normally, selectivity and affinity tend to be
correlated; and nanomolar affinities are thought to be
required, for example, in protein-inhibitor interactions
to gain selectivity (Ohtaka et al., 2004). By contrast, the
allosteric mechanism requires part of the ‘‘intrinsic bind-
ing energy’’ (Jencks, 1989) of the protein-peptide inter-
action to be used to change the shape of the protein
(Goldsmith, 1996; Strajbl et al., 2003). Thus, the micro-
molar affinities of docking motifs (Zhou et al., 2001)
may reflect larger intrinsic binding energies (Romero
et al., 1997).
Conclusions
The crystal structure of inactive ERK2 in complex with
a D motif peptide derived from HePTP reveals that the
D motif binding site encompasses both the CD site
and hydrophobic docking groove observed previously.
The three MAP kinases, ERK2, p38a, and JNK1, use to-
pologically similar binding sites to interact with D motifs.
However, amino acid replacements among the kinases
are subtly exploited to achieve specificity. Long-range
conformational changes are induced by docking inter-
actions, particularly in the activation loop. Both the
unique D motif binding interactions and the unique con-
formational changes observed in different MAP kinases
are likely mechanisms for generating specificity among
MAP kinases. Future studies are required to determine
whether docking motif interactions in active MAP
kinases induce similar conformational changes and to
understand the differences between substrate-derived
and processing enzyme-derived D motif complexes.
Experimental Procedures
Expression and Purification
Low-activity ERK2 was expressed as described previously (Zhang
et al., 1993) in Rosseta (DE3)-pLysS cells as an N-terminal His6
fusion protein and was purified by Ni-NTA agarose (Qiagen) and
Mono Q (Pharmacia) columns. The ERK2 mutant, ERK2/T116C,
was made with QuickChange (Stratagene) and confirmed by se-
quencing. The ERK2/T116C mutant was expressed and purified by
the same protocols as the wild-type ERK2. The purified protein
was then exchanged to storage buffer (30 mM HEPES [pH 7.5],
100 mM NaCl, 1 mM EDTA, and 1 mM DTT).
Crystallization and Data Collection
The 16-mer peptide (pepHePTP, 16RLQERRGSNVALMLDV31,
16RLQERRGSNVALMLDC31 in the cysteine mutant) derived from he-
matopoietic protein tyrosine phosphatase (Zhou et al., 2001) was
custom synthesized and purified in the protein chemistry facility at
UT Southwestern. Before crystallization, a 2.5-fold molar excess of
pepHePTP was added to ERK2 at low-protein concentration
(1 mg/ml ERK2) and the mixture was concentrated to w8 mg/ml.
The formation of the complex was confirmed in native protein gels
(data not shown). The ERK2/T116C-pepHePTP/V310C complex
was made by the same protocol, except that the dilute mixture
was dialyzed against DTT-free storage buffer (30 mM HEPES [pH
7.5], 0.1 M NaCl) overnight before concentrating. Crystals of bothcomplexes were grown in hanging drops at 20ºC by mixing 1.5 ml
protein/peptide solution with 1.5 ml well solution containing 20%
PEG 4000, 10% isopropanol, and 0.1M sodium HEPES (pH 7.5) iden-
tified in Crystal Screen I (Hampton Research, Laguna Miguel, CA).
Crystals of ERK2 in complex with a MEK2-derived peptide (MLAR
RKPVLPALTINP, pepMEK2) were formed under very similar condi-
tions. Crystals of all three complexes (ERK2-pepHePTP, ERK2-
pepHePTPm, and ERK2-pepMEK2) belong to space group
P212121, different from inactive ERK2 alone (Zhang et al., 1994). All
crystals were cryoprotected in reservoir solution supplemented
with 30% PEG 200 before data collection. Crystal data sets were col-
lected at APS beamline 19BM (ERK2-pepHePTP) or 19ID (ERK2-
pepHePTPm) at 90 K by using a RAXIS IV detector equipped with
a Rigaku RU300 generator (ERK2-pepMEK2) at 100 K. Diffraction
images were indexed, integrated, and scaled with DENZO and
SCALEPACK (Otwinowski and Minor, 1997).
Structure Determination and Refinement
The structure of the ERK2-pepHePTP, ERK2-pepHePTPm, and
ERK2-pepMEK2 complexes was determined by molecular replace-
ment with the program AmoRe (Navaza, 1994) by using inactive
ERK2 (Protein Data Bank code 1ERK) as the search model. After
rigid-body and positional refinements by using CNS (Brunger
et al., 1998), electron density maps calculated with the model
revealed clear density for ERK2 (at 2.9 A˚) and all residues of the pep-
tide except Val310 in ERK2-pepHePTP and all residues in ERK2-
pepHePTPm. The peptide was modeled in both structures. Full re-
finement was carried out for the ERK2-pepHePTPm structure based
on data to 1.9 A˚ (Table 1) with several cycles of manual refitting in O
(Jones et al., 1991) and further refinements with the program CNS
(Brunger et al., 1998). The wild-type complex ERK2-pepMEK2 was
partially refined to an R factor of 24% on data to 2.9 A˚, and ERK2-
pepMEK2 was partially refined to an R factor of 27% on data to
2.0 A˚ (Table 1). The electron density for the peptide in ERK2-
pepMEK2 was weak, but the protein has a structure very similar to
that of ERK2 in ERK2-pepHePTP.
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